-
Mashup Score: 2
Johns Hopkins Ciccarone Center for the Prevention of Atherosclerotic Cardiovascular Disease, Baltimore, MD, USA Division of Cardiovascular Medicine, University of California San Diego, La Jolla, CA Published by Elsevier on Behalf of The American College of Cardiology Foundation. Received March 6, 2024 Accepted March 8, 2024 Published online March 25,
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 5Distribution of Coronary Artery Calcium by Age, Sex and Race among Patients 30–45 Years Old - 2 month(s) ago
Coronary artery calcium (CAC) is a measure of atherosclerotic burden and well-validated for risk stratification in middle- to older-aged adults. Few studies have investigated CAC in younger adults, and there is no calculator for determining age, sex, …
Source: www.ncbi.nlm.nih.govCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0Prevalence of Aortic Valve Calcium and the Long-Term Risk of Incident Severe Aortic Stenosis - PubMed - 9 month(s) ago
The probability of AVC >0 varied significantly by age, sex, and race/ethnicity. The risk of severe AS was exponentially higher with higher AVC scores, whereas AVC = 0 was associated with an extremely low long-term risk of severe AS. The measurement of AVC provides clinically relevant information …
Source: pubmed.ncbi.nlm.nih.govCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 10Coronary artery calcium: from risk prediction to treatment allocation and clinical trials - 9 month(s) ago
Coronary artery calcium (CAC) is a direct measure of an individual’s coronary atherosclerotic burden. Higher levels of CAC are strongly associated with an increased risk of cardiovascular disease (CVD) events and individuals with very high CAC levels have a CVD risk similar to stable persons with a prior CVD event. Conversely, the absence of CAC (CAC=0) is associated with a low long-term risk of CVD, even among groups classified as high risk based on traditional risk factors. Accordingly, the guideline-based role of CAC in allocation of CVD prevention therapies has expanded to include both statin and non-statin medications. Beyond prevention therapies, it is now widely recognised that the total burden of atherosclerosis is a stronger risk factor for CVD than a sole focus on coronary stenosis. Furthermore, evidence is accruing to support expanding the value of CAC=0 among low-risk symptomatic patients given its very high negative predictive value for ruling out obstructive coronary arte
Source: heart.bmj.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 4Assessment of cardiovascular disease risk: a 2023 update - PubMed - 10 month(s) ago
Lp(a) concentration and CAC scoring, apart from the traditional risk factors, add the most value to the current CVD risk assessment approaches OF ALL AVAILABLE TOOLS, especially in terms of guiding LLT. In addition to new integrative tools such as the MESA CHD Risk Score and Coronary Age calculator, …
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2FDA Approves Colchicine for Decreasing CV Events - 10 month(s) ago
(UPDATED) In a big moment for the “inflammatory hypothesis,” the drug, to be sold as Lodoco, is the first anti-inflammatory for CVD.
Source: TCTMD.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1Advanced subclinical atherosclerosis: A novel category within the cardiovascular risk continuum with distinct treatment implications - PubMed - 1 year(s) ago
Traditionally, guidelines divide patients into primary and secondary prevention for atherosclerotic cardiovascular disease (ASCVD) risk management. However, the modern understanding of the biological progression of atherosclerosis is inconsistent with this binary approach. Therefore, a new approach …
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Advanced subclinical atherosclerosis: A novel category within the cardiovascular risk continuum with distinct treatment implications - PubMed - 1 year(s) ago
Traditionally, guidelines divide patients into primary and secondary prevention for atherosclerotic cardiovascular disease (ASCVD) risk management. However, the modern understanding of the biological progression of atherosclerosis is inconsistent with this binary approach. Therefore, a new approach …
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS - 1 year(s) ago
Given the positive results from the trial, the US FDA approved semaglutide for obese/overweight teenagers.
Source: TCTMD.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
Predicting Age of Conversion to CAC >0: A Role for Polygenic Risk Scores?
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet
RT @hsbhatia: I enjoyed contributing to the editorial for this paper with @MichaelJBlaha https://t.co/HVRuemH1q3